Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2003
06/25/2003EP1321474A1 A method for inducing apoptosis
06/25/2003EP1321473A1 Method of preventing decrease in the activity of protein due to freezing and use of polypeptide in the production of protein activity decrease preventing agent
06/25/2003EP1321472A2 Elicitor of fungal origin and method for its preparation
06/25/2003EP1320750A2 Methods for identifying agents causing a lethal phenotype
06/25/2003EP1320624A2 Silicatein-mediated synthesis of amorphous silicates and siloxanes and use thereof
06/25/2003EP1320623A1 Promoter sequences
06/25/2003EP1320621A2 Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications
06/25/2003EP1320620A2 Production of viral vectors
06/25/2003EP1320618A2 Nucleotide sequences mediating male fertility and method of using same
06/25/2003EP1320616A2 Sequences which code for the sige gene of corynebacterium glutamicum
06/25/2003EP1320609A2 Isolated peptides which bind to hla-c molecules and uses thereof
06/25/2003EP1320608A1 Nucleotide sequences which code for the msik gene
06/25/2003EP1320607A2 HYPERSENSITIVE RESPONSE ELICITOR FROM i XANTHOMONAS CAMPESTRIS /i
06/25/2003EP1320606A2 Identification and cloning of a full-length human cink-related gene, mist (mast cell immunoreceptor signal transducer)
06/25/2003EP1320605A2 Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22 and uses thereof
06/25/2003EP1320604A2 Cripto mutant and uses thereof
06/25/2003EP1320603A1 Uses of the gjb6 gene for treating certain types of alopecia including the clouston's syndrome, and for screening compounds capable of being efficient in the treatment of alopecia with genetic susceptibility
06/25/2003EP1320602A2 Spas-1 cancer antigen
06/25/2003EP1320601A1 Human and rat pgc-3, ppar-gamma coactivations and splice variants thereof
06/25/2003EP1320600A1 Transporters and ion channels
06/25/2003EP1320599A2 Pd-l2 molecules: pd-1 ligands and uses therefor
06/25/2003EP1320598A2 Polypeptides and corresponding molecules for disease detection and treatment
06/25/2003EP1320595A2 Production process of surfactin
06/25/2003EP1320594A2 Exbb-exbd-tonb gene cluster of pseudomonas putida dot-t1e conferring tolerance to aromatic compounds and resistance to antibiotics
06/25/2003EP1320582A2 Adenovirus e1b-55k single amino acid mutants and methods of use
06/25/2003EP1320550A2 G-protein coupled receptors
06/25/2003EP1320549A2 Pumpcn compositions and uses thereof
06/25/2003EP1320548A2 Transporters and ion channels
06/25/2003EP1320547A1 Transfer factor from birds eggs
06/25/2003EP1320546A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof
06/25/2003EP1320545A2 Recombinant endothelial cell growth inhibitors derived from a mammalian plasminogen
06/25/2003EP1320543A2 Nucleotide sequence coding for the sigc gene of corynebacterium glutamicum
06/25/2003EP1320542A2 Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof
06/25/2003EP1320541A2 Tgf-beta inhibitors and methods
06/25/2003EP1320540A2 Peptidomimetic protease inhibitors
06/25/2003EP1320538A2 Process for the preparation of 5-phenylpentanoyl-ala-argl-ala- 2-[3-amino-2-oxopyrrolidin-1-yl]propionyl - ala-arg-ala-4-aminophenylacetamide
06/25/2003EP1320384A1 The synergetic effects of hgf and antibacterial treatment
06/25/2003EP1320377A1 Hla binding peptides and their uses
06/25/2003EP1320376A2 Treatment of prostate cancer
06/25/2003EP1280545A4 Cross-linked collagen matrices and methods for their preparation
06/25/2003EP1233985A4 Collagen
06/25/2003EP1071704B1 Novel matrix metalloproteinase inhibitors and down-regulators
06/25/2003EP1025125B1 Aggregates of human insulin derivatives
06/25/2003EP0941365B1 Novel probes for the detection of mycobacteria
06/25/2003EP0877807B1 Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity
06/25/2003EP0854924B1 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
06/25/2003EP0840615B1 Chemokine binding protein and methods of use therefor
06/25/2003EP0828852B1 Methods for detection and therapy of squamous cell carcinoma and bladder carcinoma, in particular for determining the presence and treatment of minimal residual disease, micrometastases or dissemination of such carcinoma types
06/25/2003EP0753073B1 Heat-inducible n-degron module
06/25/2003EP0678121B1 Methods and reagents for inhibiting furin endoprotease
06/25/2003EP0668879B1 Truncated insulin-like growth factor binding proteins having mitogenic activity
06/25/2003EP0650524B1 Detection of the cytolysin gene with oligonucleotides
06/25/2003EP0620849B1 Transgenic animal models for alzheimer's disease
06/25/2003EP0573603B1 Inhibitors of human neutrophil elastase and human cathepsin g
06/25/2003EP0480024B1 Dna encoding plant thioesterases
06/25/2003CN1426482A Diagnostics and therapeutics for glaucoma
06/25/2003CN1426478A Prion-free transgenic ungulates
06/25/2003CN1426477A 方法 Method
06/25/2003CN1426474A Novel promoters and gene expression method by using same
06/25/2003CN1426473A Heterologous expression of neisserial proteins
06/25/2003CN1426472A Nucleic acid construct encoding processing component derived from N-terminal region of hepatitis virus ORF2, and an antigenic polypeptide
06/25/2003CN1426471A Hybrid expression of neisserial proteins
06/25/2003CN1426468A KCNB: novel potassium channel protein
06/25/2003CN1426467A Thrombopoietin receptor modulating peptide
06/25/2003CN1426464A Gene of IL-12 p40 subunit mutated for improving activity of IL-12 and use thereof for DNA vaccine adjuvant
06/25/2003CN1426462A Pneumovirus NS proteins antagonising interferon (IFN) response
06/25/2003CN1426460A 方法 Method
06/25/2003CN1426422A 修饰的bdnf Modified bdnf
06/25/2003CN1426421A Tumour-specific animal proteins
06/25/2003CN1426420A Novel proteins and novel genes encoding same
06/25/2003CN1426307A 蛋白质 Protein
06/25/2003CN1426306A Method and compositions for impairing multiplication of HIV-1
06/25/2003CN1425770A Plant cytoplasmic male sterile recovering gene and its use
06/25/2003CN1425690A Use of degrease filter plate in separating process of human blood albumin
06/25/2003CN1425689A Polypeptide-humand big protem 1196-31.79 and polynucleotide for encoding such polypeptide
06/25/2003CN1425688A Polypeptide-transcription factor protein-9.35 and polynucleotide for encoding such polypeptide
06/25/2003CN1425687A Polypeptide-protein-70.95 containing actin binding structural domain and polynucleotide for encoding such polypeptide
06/25/2003CN1425686A Polypeptide-glycoprotein-9.02 and polynucleotide for encoding such polypeptide
06/25/2003CN1425685A Polypeptide-human protein-9.35 containing glycoprotein structural domain and polynucleotide for encoding such polypeptide
06/25/2003CN1425684A Polypeptide-human reverse transcription transposition 40 protein-12.76 and polynucleotide for encoding such polypeptide
06/25/2003CN1425683A Polypeptide-flavoprotein subunit-9.68 and polynucleotide for encoding such polypeptide
06/25/2003CN1425682A Polypeptide-protein-11.99 containing ribosomal protein L16 structural domain and polynucleotide for encoding such polypeptide
06/25/2003CN1425681A Protein and nucleic acid for therapy
06/25/2003CN1425677A New gene SNX21 of human SNX family
06/25/2003CN1425675A Cotton Na+/H+ reverse transport protein gene and its cloning method and use
06/25/2003CN1112445C Control of plant gene expression
06/25/2003CN1112444C Method for controlling water content of plant
06/25/2003CN1112367C Use of pharmaceutical composition comprising appetite-suppressing peptide
06/25/2003CN1112105C Insect control with multiple toxins
06/24/2003US6583337 Nucleotide sequences coding transport protein for use in the generation of disease and herbicide resistant plants
06/24/2003US6583277 Which regulate cellular guidance and physiology, and related nucleic acids.
06/24/2003US6583276 Nucleotide sequences coding polypeptide for use in the treatment of cardiovascular disorders
06/24/2003US6583275 Nucleotide sequences coding polypeptied for use in the treatment, diagnosis and prevention of bacterial infection
06/24/2003US6583272 Protein conjugate for use in the treatment of blood disorders
06/24/2003US6583271 Use of thiol redox proteins for reducing protein intramolecular disulfide bonds, for improving the quality of cereal products, dough and baked goods and for inactivating snake, bee and scorpion toxins
06/24/2003US6583270 Interleukin-19
06/24/2003US6583269 Human protease inhibitor and polynucleotides encoding the same
06/24/2003US6583267 Polyethylene glycol derivative modifying granulocyte colony stimulating factor activity
06/24/2003US6583266 Peptide for use in the diagnosis and treatment of skin disorders and tuberculosis
06/24/2003US6583264 Insecticidal compounds and methods for selection thereof